Scientists Develop Universal Cancer Vaccine Using mRNA Technology
By
01-_-
Pure flour-power. Hearty enough to carry you through lunch.
Summary
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer, potentially eliminating the need for traditional cancer treatments like chemotherapy and surgery.
Key quotes
· 3 pulledIt has the potential to do away with chemotherapy, surgery and radiation treatment.
University of Florida (UF) scientists have developed an experimental vaccine that dramatically boosts the immune system’s ability to fight tumors – even without targeting a specific cancer type.
This 'general purpose' mRNA jab works in a similar way to a Covid-19 vaccine.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·38m ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·1h ago
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
bbc.co.uk·4h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·5h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h ago